Myasthenia Gravis Treatments
Find Myasthenia Gravis Treatments
Pyridostigmine
What is Mestinon (Pyridostigmine)?
Approved To Treat
Top Global Experts
Related Clinical Trials
Summary: The LIFT will be conducted at Brigham and Women's Hospital (BWH) of Harvard Medical School, focusing on the effect of Pyridostigmine (Mestinon) and Low-Dose Naltrexone (LDN) in subjects aged 18-70 meeting the Canadian consensus criteria (CCC) for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) as well as having specifically Orthostatic Intolerance (OI). Long COVID (LC) subjects will al...
Objective: This study aims to evaluate the incidence, severity, and risk factors of sugammadex-induced mouth clenching during neuromuscular blockade (NMB) reversal in adult surgical patients. Study
Summary: This is a 3-day study comparing pyridostigmine versus placebo in the treatment of postural tachycardia syndrome (POTS). The researchers expect pyridostigmine to improve tachycardia and stabilize blood pressure.
Related Latest Advances
Brand Information

- Osserman KE, Genkins G. Studies in myasthenia gravis: Reduction in mortality rate after crisis.
- Osserman KE, Genkins G. Studies in myasthenia gravis.
- Grob D. Myasthenia gravis. A review of pathogenesis and treatment.
- Schwab RS. Management of myasthenia gravis.
- Schwab RS. Management of myasthenia gravis.
- Cronnelly R, Stanski DR, Miller RD, Sheiner LB. Pyridostigmine kinetics with and without renal function.
- Miller RD. Pharmacodynamics and pharmacokinetics of anticholinesterase. In: Ruegheimer E, Zindler M, ed.
- Breyer-Pfaff U, Maier U, Brinkmann AM, Schumm F. Pyridostigmine kinetics in healthy subjects and patients with myasthenia gravis.
Rx Only
(pyridostigmine
bromide).
Oral Solution,
USP
5 mL =
60 mg
pyridostigmine bromide.

Rx Only
(pyridostigmine bromide)
Tablets, USP
Usual Dosage: See accompanying package insert.
Store at 25°C (77°F); excursions permitted to 15° to 30°C (59° to 86°F).

Rx Only
MESTINON®
(pyridostigmine
bromide)
TIMESPAN
Tablets
in a specially constructed tablet for sustained release
BAUSCH Health9549902
50104061C


